Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2
Abstract The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was
developed with a consensus-based process using a combination of published data, and …
developed with a consensus-based process using a combination of published data, and …
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
FJH Drost, DF Osses, D Nieboer… - Cochrane Database …, 2019 - cochranelibrary.com
Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …
Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial
LGW Kerkmeijer, VH Groen, FJ Pos… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This study investigates whether focal boosting of the macroscopic visible tumor
with external beam radiotherapy increases biochemical disease-free survival (bDFS) in …
with external beam radiotherapy increases biochemical disease-free survival (bDFS) in …
[HTML][HTML] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Background Men with high serum prostate specific antigen usually undergo transrectal
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects …
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …
Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane …
FJH Drost, D Osses, D Nieboer, CH Bangma… - European urology, 2020 - Elsevier
Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …
Classification of cancer at prostate MRI: deep learning versus clinical PI-RADS assessment
Background Men suspected of having clinically significant prostate cancer (sPC)
increasingly undergo prostate MRI. The potential of deep learning to provide diagnostic …
increasingly undergo prostate MRI. The potential of deep learning to provide diagnostic …
PI-RADS prostate imaging–reporting and data system: 2015, version 2
Abstract The Prostate Imaging–Reporting and Data System Version 2 (PI-RADS™ v2) is the
product of an international collaboration of the American College of Radiology (ACR) …
product of an international collaboration of the American College of Radiology (ACR) …
Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer
Importance Targeted magnetic resonance (MR)/ultrasound fusion prostate biopsy has been
shown to detect prostate cancer. The implications of targeted biopsy alone vs standard …
shown to detect prostate cancer. The implications of targeted biopsy alone vs standard …
Current use of PSMA–PET in prostate cancer management
T Maurer, M Eiber, M Schwaiger… - Nature Reviews …, 2016 - nature.com
Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …